Helicobacter pylori and plasma ammonia levels in cirrhotics: Role of urease inhibition by acetohydroxamic acid

Italian Journal of Gastroenterology and Hepatology

Volumn 30, Issue 4, 1998, Pages 405-409

  Zullo, A ^a   Rinaldi, V ^a   Hassan, C ^a   Folino, S ^a   Winn, S ^a   Pinto, G ^a   Attili, A F ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Acetohydroxamic acid; Ammonia; Cirrhosis; Helicobacter pylori; Urease

Indexed keywords

ACETOHYDROXAMIC ACID; AMMONIA; UREASE; UREASE INHIBITOR;

ADULT; AMMONIA BLOOD LEVEL; ARTICLE; BACTERIAL COUNT; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL MUCOSA; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; HUMAN TISSUE; HYPERAMMONEMIA; LABORATORY TEST; LIVER CIRRHOSIS; MALE; ORAL DRUG ADMINISTRATION; STATISTICAL ANALYSIS;

AGED; AMMONIA; FEMALE; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; HYDROXAMIC ACIDS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC; UREASE;

EID: 0031694053     PISSN: 11258055     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Marshall BJ, Langton SR. Urea hydrolysis in patients with Campylobacter pyloridis infection. Lancet 1986;i:965-6.
2. Owen RJ. Bacteriology of Helicobacter pylori. In Calam J editor. Helicobacter pylori. Baillere's Clin Gastroenterol 1995;9:415-46.
3. Le Veen HH, Le Veen EG, Le Veen RR Awakenings to the pathogenicity of urease and the requirement for continuous long term therapy. Biomed Pharmacother 1994;48:157-66.
4. Gubbins GP, Moritz TE, Marsano LS, Talwalkar R, McClain CJ, Mendenhall CL. Helicobacter pylori is a risk factor for hepatic encephalopathy in acute alcoholic hepatitis: the ammonia hypothesis revised. Am J Gastroenterol 1993;11:1906-10.
5. Attili AF, Rinaldi V, Caschera M, Cedola M. Helicobacter pylori: a major determinant of serum ammonia levels in cirrhotic patients? Hepatology 1994;20:A56.
6. Cho YD, Bong HK, Leq YH, Kirn JO, Cho JY, Kim YS, et al. The role of gastric H. pylori infection on the blood level of ammonia in patients with liver cirrhosis. Gastroenterology 1997;112:A89.
7. Al-Kareemy EAR, Zakhary MM. Helicobacter pylori: is it a risk factor for hepatic encephalopathy in cirrhotic patients? Gut 1996;39A:121.
8. Miyaii H, Ito S, Azuma T, Ito Y, Yamazaki Y, Ohtaki Y, et al. Effects of Helicobacter pylori eradication therapy on hyperammonaemia in patients with liver cirrhosis. Gut 1997;40:726-30.
9. Rossle M, Haag K, Ochs A, Deibert P, Siegerstetter V, Kist M. Helicobacter pylori is not associated with an increased risk of hepatic encephalopathy. Hepatology 1994;20:A57.
10. Kirchner GI, Wagner S, Schmidt H, Gevel M, Harms CP, Meier P, et al. Pathogenic role of Helicobacter pylori infection in chronic liver disease. Gastroenterology 1996;110:A157.
11. Schmulson M, De Leon G, Keschenoeich A, Vargas F, Kershenobich D. Helicobacter pylori infection among patients with alcoholic and non-alcoholic cirrhosis. Gastroenterology 1996; 110:A253.
12. Plevris JN, Morgenstern R, Hayes PC, Bouchier IAD. Hyperammonaemia in cirrhosis and Helicobacter pylori infection. Lancet 1995;ii: 1104 (letter).
13. Ito S, Miyaji H, Azuma T, Youming L. Hyperammonaemia and Helicobacter pylori. Lancet 1995;i:124-5 (letter).
14. Quero JC, Hartmann IJC, de Rooij F, Wilson JHP. Hyperammonaemia and Helicobacter pylori. Lancet 1995;ii:713-4 (letter).
15. Goldie J, Zeldhuyzen van Zanten S3, Jalali R, Richardson H, Hunt RH. Inhibition of urease activity but not growth of Helicobacter pylori by acetohydroxamic acid. J Clin Pathol 1991;44:695-7.
16. El Nujumi AM, Dorrian CA, Chittajallu RS, Neithercut WD, McColl KEL. Effect of inhibition of Helicobacter pylori urease activity by acetohydroxamic acid on serum gastrin in duodenal ulcer patients. Gut 1991;32:866-70.
17. Wolpert E, Hoiman AF, Summerskill WHJ. Synthesis and metabolism of labeled acetohydroxamic acid, a urease inhibitor. Proc Soc Exp Biol Med 1971;136:592-6.
18. Feldman S, Putcha L, Griffith DP. Pharmacokinetics of acetohy-droxamic acid. Invest Urol 1978;15:498-501.
19. Pugh RNH, Murray-Lyo IM, Dawson JI, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646-9.
20. Japanese Research Society for Portal Hypertension. The general rules for recording endoscopie findings of esophageal varices. JpnJSurg 1980;10:84-7.
21. Hashizume M, Kitano S, Yamaga H, Koyanagi N, Sugimachi K. Endoscopie classification of gastric varices. Gastrointest Endosc 1990,36:276-80..
22. Me Cormick PA, Sankey EA, Cardin F, Dhillon AP, Mclntyre N, Burroughs AK. Congestive gastropathy and Helicobacter pylori: an endoscopie and morphometric study. Gut 1991;32:351-4.
23. Talamini G, Zamboni G, Cavallini G. Antrat mucosal Helicobacter pylori infection density as a risk factor of duodenal ulcer. Digestion 1997;58:211-7.
24. Rudman D, Di Fulco TJ, Galambos JT. Maximal rates of urea syntesis in normal and cirrhotic subjects. J Clin Invest 1973;52:2241-6.
25. Dasani BM, Sigal SH, Lieber CS. The role of Helicobacter pylori in the pathogenesis and treatment of chronic hepatic encephalopathy. Hepatology 1995;22:A161.
26. Rinaldi V, Zullo A, Diana F, Capocaccia L. Helicobacter pylori, hyperammonaemia, and hepatic encephalopathy: is there a correlation? Am J Gastroenterol 1997;92:723-4 (letter).
27. Taylor-Robinson SD, Jackson N, Buckley C. Helicobacter pylori, ammonia and the brain. Gut 1997;40:805-6.
28. McColm AA, Bagshaw JA, O'Malley CF. Development of a 14C-urea breath test in ferrets colonised with Helicobacter mustelae: effects of treatment with bismuth, antibiotics, and urease inhibitors. Gut 1993;34:181-6.
29. Griffith DP, Gibson JR, Clinton CW, Musher DM. Acetohydroxamic acid: clinical studies of a urease inhibitor in patients with staghom renal calculi. J Urol 1978;! 19:9-14.
30. Williams JJ, Rodman JS, Peterson CM. A randomized double-blind study of acetohydroxamic acid in struvite nephrolithiasis. N Eng J Med 1984;311:760-4.
31. Deutz NEP, Dejong CHC, Soeters PB. Ammonia and glutamine metabolism during liver insufficiency: the muscle-gut-liver axis. Ital J Gastroenterol 1993;25:79-86.
32. Wolpert E, Phillips SJ, Summerskill DHJ. Transport of urea and ammonia production in the human colon. Lancet 1971;ii:1387-90.
33. Bergmeyer HV, Beutler HO. Ammonia. In Bergmeyer HV, editor. Methods of enzymatic analysis. Weinheim Verlag Chemie; New York: Academic Press:, 1974:454-61.
34. Nomura F, Ohnishi K, Terabayashi H, Nakal T, Isobe K, Takekoshi K, et al. Effect of intrahepatic portal-systemic shunting on hepatic ammonia extraction in patients in liver cirrhosis. Hepatology 1994;20:1478-81.